{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:10:31Z","timestamp":1792203031683,"version":"4.4.0"},"reference-count":66,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/or.2015.3987","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T07:35:37Z","timestamp":1432020937000},"page":"279-287","source":"Crossref","is-referenced-by-count":21,"title":["Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines"],"prefix":"10.3892","volume":"34","author":[{"given":"SILVIA","family":"CODENOTTI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHELA","family":"BATTISTELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SABRINA","family":"BURATTINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SARA","family":"SALUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELISABETTA","family":"FALCIERI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RITA","family":"REZZANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FIORELLA","family":"FAGGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARINA","family":"COLOMBI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUGENIO","family":"MONTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALESSANDRO","family":"FANZANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"key20180107212501_b1-or-34-01-0279","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-12-380916-2.00007-3","article-title":"Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle","volume":"94","author":"Saab","year":"2011","journal-title":"Curr Top Dev Biol"},{"key":"key20180107212501_b2-or-34-01-0279","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.sempedsurg.2011.10.007","article-title":"Update on rhabdomyosarcoma","volume":"21","author":"Dasgupta","year":"2012","journal-title":"Semin Pediatr Surg"},{"issue":"Suppl 1","key":"key20180107212501_b3-or-34-01-0279","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.2350\/10-12-0953-PB.1","article-title":"Myogenic tumors in children and adolescents","volume":"15","author":"Parham","year":"2012","journal-title":"Pediatr Dev Pathol"},{"key":"key20180107212501_b4-or-34-01-0279","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975\u20132005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"key":"key20180107212501_b5-or-34-01-0279","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2009.26.3814","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","author":"Williamson","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107212501_b6-or-34-01-0279","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ccr.2013.11.002","article-title":"St. Jude Children\u2019s Research Hospital-Washington University Pediatric Cancer Genome Project: Targeting oxidative stress in embryonal rhabdomyosarcoma","volume":"24","author":"Chen","year":"2013","journal-title":"Cancer Cell"},{"key":"key20180107212501_b7-or-34-01-0279","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1078-0432.CCR-11-2056","article-title":"Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways","volume":"18","author":"Shukla","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107212501_b8-or-34-01-0279","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","author":"Shern","year":"2014","journal-title":"Cancer Discov"},{"key":"key20180107212501_b9-or-34-01-0279","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1535-7163.MCT-10-0695","article-title":"Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma","volume":"10","author":"Abraham","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107212501_b10-or-34-01-0279","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","author":"Taylor","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180107212501_b11-or-34-01-0279","doi-asserted-by":"crossref","first-page":"756982","DOI":"10.1155\/2011\/756982","article-title":"Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma","volume":"2011","author":"Crose","year":"2011","journal-title":"Sarcoma"},{"key":"key20180107212501_b12-or-34-01-0279","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/sj.onc.1210467","article-title":"Loss of suppressor-of-fused function promotes tumorigenesis","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"key20180107212501_b13-or-34-01-0279","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-06-1344","article-title":"Phosphoprotein pathway mapping: Akt\/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival","volume":"67","author":"Petricoin","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107212501_b14-or-34-01-0279","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2013.05.010","article-title":"Synthetic lethal interaction between PI3K\/Akt\/mTOR and Ras\/MEK\/ERK pathway inhibition in rhabdomyosarcoma","volume":"337","author":"Guenther","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107212501_b15-or-34-01-0279","doi-asserted-by":"crossref","first-page":"28341","DOI":"10.1074\/jbc.C000352200","article-title":"Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma","volume":"275","author":"Hahn","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107212501_b16-or-34-01-0279","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2044-5040-2-25","article-title":"Alveolar rhabdomyosarcoma-The molecular drivers of PAX3\/7-FOXO1-induced tumorigenesis","volume":"2","author":"Marshall","year":"2012","journal-title":"Skelet Muscle"},{"key":"key20180107212501_b17-or-34-01-0279","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng0293-113","article-title":"Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma","volume":"3","author":"Barr","year":"1993","journal-title":"Nat Genet"},{"key":"key20180107212501_b18-or-34-01-0279","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/sj.onc.1210835","article-title":"PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis","volume":"27","author":"Graf Finckenstein","year":"2008","journal-title":"Oncogene"},{"key":"key20180107212501_b19-or-34-01-0279","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1111\/febs.12421","article-title":"Mechanisms of impaired differentiation in rhabdomyosarcoma","volume":"280","author":"Keller","year":"2013","journal-title":"FEBS J"},{"key":"key20180107212501_b20-or-34-01-0279","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1749-6632.2000.tb05403.x","article-title":"Gene regulation by melatonin","volume":"917","author":"Carlberg","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"key20180107212501_b21-or-34-01-0279","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-079X.2011.00856.x","article-title":"A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases","volume":"51","author":"Stehle","year":"2011","journal-title":"J Pineal Res"},{"key":"key20180107212501_b22-or-34-01-0279","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/biof.23","article-title":"Melatonin: Signaling mechanisms of a pleiotropic agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"Biofactors"},{"key":"key20180107212501_b23-or-34-01-0279","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1210\/en.2007-0804","article-title":"Minireview: Entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals","volume":"148","author":"Challet","year":"2007","journal-title":"Endocrinology"},{"key":"key20180107212501_b24-or-34-01-0279","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2008.09.017","article-title":"ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells","volume":"46","author":"Luchetti","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"key20180107212501_b25-or-34-01-0279","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1096\/fj.10-154450","article-title":"Melatonin signaling and cell protection function","volume":"24","author":"Luchetti","year":"2010","journal-title":"FASEB J"},{"key":"key20180107212501_b26-or-34-01-0279","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-079X.2007.00518.x","article-title":"Cardiovascular diseases: Protective effects of melatonin","volume":"44","author":"Tengattini","year":"2008","journal-title":"J Pineal Res"},{"key":"key20180107212501_b27-or-34-01-0279","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jpi.12162","article-title":"Melatonin: A well-documented antioxidant with conditional pro-oxidant actions","volume":"57","author":"Zhang","year":"2014","journal-title":"J Pineal Res"},{"key":"key20180107212501_b28-or-34-01-0279","first-page":"425","article-title":"Anticarcinogenic role of melatonin - potential mechanisms","volume":"62","author":"Bukowska","year":"2011","journal-title":"Med Pr"},{"key":"key20180107212501_b29-or-34-01-0279","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1534735409352086","article-title":"Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms","volume":"8","author":"Hrushesky","year":"2009","journal-title":"Integr Cancer Ther"},{"key":"key20180107212501_b30-or-34-01-0279","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr2794","article-title":"Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway","volume":"12","author":"Mao","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20180107212501_b31-or-34-01-0279","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.2174\/092986710794183015","article-title":"Basic mechanisms involved in the anti-cancer effects of melatonin","volume":"17","author":"Mediavilla","year":"2010","journal-title":"Curr Med Chem"},{"key":"key20180107212501_b32-or-34-01-0279","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/onc.2011.469","article-title":"Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation","volume":"31","author":"Santoro","year":"2012","journal-title":"Oncogene"},{"key":"key20180107212501_b33-or-34-01-0279","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/jnci\/djr044","article-title":"Rotating night shifts and risk of skin cancer in the nurses\u2019 health study","volume":"103","author":"Schernhammer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key20180107212501_b34-or-34-01-0279","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jpi.12060","article-title":"Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP","volume":"55","author":"Fan","year":"2013","journal-title":"J Pineal Res"},{"key":"key20180107212501_b35-or-34-01-0279","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bone.2013.02.021","article-title":"Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63","volume":"55","author":"Liu","year":"2013","journal-title":"Bone"},{"key":"key20180107212501_b36-or-34-01-0279","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-079X.2005.00270.x","article-title":"Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation","volume":"39","author":"Trubiani","year":"2005","journal-title":"J Pineal Res"},{"key":"key20180107212501_b37-or-34-01-0279","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jpi.12119","article-title":"Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells","volume":"56","author":"Hong","year":"2014","journal-title":"J Pineal Res"},{"key":"key20180107212501_b38-or-34-01-0279","doi-asserted-by":"crossref","first-page":"e85311","DOI":"10.1371\/journal.pone.0085311","article-title":"Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer","volume":"9","author":"Jardim-Perassi","year":"2014","journal-title":"PLoS One"},{"key":"key20180107212501_b39-or-34-01-0279","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-079X.2010.00823.x","article-title":"Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model","volume":"50","author":"Jung-Hynes","year":"2011","journal-title":"J Pineal Res"},{"key":"key20180107212501_b40-or-34-01-0279","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jpi.12142","article-title":"Antitumour activity of melatonin in a mouse model of human prostate cancer: Relationship with hypoxia signalling","volume":"57","author":"Paroni","year":"2014","journal-title":"J Pineal Res"},{"key":"key20180107212501_b41-or-34-01-0279","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccr.2010.12.023","article-title":"Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma","volume":"19","author":"Rubin","year":"2011","journal-title":"Cancer Cell"},{"key":"key20180107212501_b42-or-34-01-0279","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett"},{"key":"key20180107212501_b43-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat Protoc"},{"key":"key20180107212501_b44-or-34-01-0279","doi-asserted-by":"crossref","first-page":"267","DOI":"10.32098\/mltj.04.2013.06","article-title":"Further considerations on in vitro skeletal muscle cell death","volume":"3","author":"Battistelli","year":"2013","journal-title":"Muscles Ligaments Tendons J"},{"key":"key20180107212501_b45-or-34-01-0279","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.3390\/ijms15046625","article-title":"Melatonin prevents chemical-induced haemopoietic cell death","volume":"15","author":"Salucci","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20180107212501_b46-or-34-01-0279","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"key20180107212501_b47-or-34-01-0279","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: Opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107212501_b48-or-34-01-0279","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol Cell"},{"key":"key20180107212501_b49-or-34-01-0279","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s11033-011-1043-4","article-title":"Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin","volume":"39","author":"Zhang","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20180107212501_b50-or-34-01-0279","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.20155","article-title":"Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism","volume":"63","author":"Sainz","year":"2005","journal-title":"Prostate"},{"key":"key20180107212501_b51-or-34-01-0279","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2002.11.004","article-title":"Melatonin: From basic research to cancer treatment clinics","volume":"20","author":"Vijayalaxmi","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180107212501_b52-or-34-01-0279","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-079X.1997.tb00322.x","article-title":"The validity of melatonin as an oncostatic agent","volume":"22","author":"Panzer","year":"1997","journal-title":"J Pineal Res"},{"key":"key20180107212501_b53-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","article-title":"Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status","volume":"35","author":"Lissoni","year":"1999","journal-title":"Eur J Cancer"},{"key":"key20180107212501_b54-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1211\/002235702760345374","article-title":"Melatonin: Reducing the toxicity and increasing the efficacy of drugs","volume":"54","author":"Reiter","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"key20180107212501_b55-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3748\/wjg.v16.i12.1473","article-title":"Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines","volume":"16","author":"Fan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"key20180107212501_b56-or-34-01-0279","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-079X.2003.2e114.x","article-title":"What constitutes a physiological concentration of melatonin?","volume":"34","author":"Reiter","year":"2003","journal-title":"J Pineal Res"},{"key":"key20180107212501_b57-or-34-01-0279","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations","volume":"52","author":"Venegas","year":"2012","journal-title":"J Pineal Res"},{"key":"key20180107212501_b58-or-34-01-0279","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0633.2002.290401.x","article-title":"Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment","volume":"29","author":"Seabra","year":"2000","journal-title":"J Pineal Res"},{"key":"key20180107212501_b59-or-34-01-0279","first-page":"373","article-title":"The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives","volume":"13","author":"Reiter","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"key20180107212501_b60-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00018-003-2319-1","article-title":"Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells","volume":"60","author":"Sainz","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"key20180107212501_b61-or-34-01-0279","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(01)02680-1","article-title":"Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells","volume":"502","author":"W\u00f6lfler","year":"2001","journal-title":"FEBS Lett"},{"key":"key20180107212501_b62-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/14728222.2013.834890","article-title":"Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: A review","volume":"17","author":"Bizzarri","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107212501_b63-or-34-01-0279","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jpi.12010","article-title":"On the free radical scavenging activities of melatonin\u2019s metabolites, AFMK and AMK","volume":"54","author":"Galano","year":"2013","journal-title":"J Pineal Res"},{"key":"key20180107212501_b64-or-34-01-0279","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1742-7843.2010.00619.x","article-title":"Pro-oxidant effect of melatonin in tumour leucocytes: Relation with its cytotoxic and pro-apoptotic effects","volume":"108","author":"Bejarano","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key20180107212501_b65-or-34-01-0279","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3109\/10715762.2011.623700","article-title":"Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells","volume":"45","author":"S\u00e1nchez-S\u00e1nchez","year":"2011","journal-title":"Free Radic Res"},{"key":"key20180107212501_b66-or-34-01-0279","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1472-8206.2005.00389.x","article-title":"Melatonin cytotoxicity in human leukemia cells: Relation with its pro-oxidant effect","volume":"20","author":"B\u00fcy\u00fckavci","year":"2006","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3987\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T02:58:52Z","timestamp":1717901932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,19]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/or.2015.3987"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3987","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}